INDV fund manager activity
Indivior Pharmaceuticals, Inc · Nasdaq. Reported by 2 tracked fund managers in their 13F filings, Q1 2026 to Q2 2026.
Q2 2026
| Manager | Activity | Shares | Value | % of portfolio | Filed |
|---|---|---|---|---|---|
| Joel Greenblatt - Gotham Asset Management | New | 94,850 | $3,891,696 | 0.01% | Aug 14, 2026 |
| Howard Marks - Oaktree Capital Management | Trimmed | 6,127,212 | $251,399,508 | 6.65% | Aug 14, 2026 |
Q1 2026
| Manager | Activity | Shares | Value | % of portfolio | Filed |
|---|---|---|---|---|---|
| Howard Marks - Oaktree Capital Management | New | 6,984,102 | $212,875,428 | 4.94% | May 20, 2026 |